Afghanistan vs Cape Verde: The number of people with susceptibility test result for rifampicin
Afghanistan
70.58
in 2021
Cape Verde
69.01
in 2021
Afghanistan rank
103rd
Cape Verde rank
105th
The number of people with susceptibility test result for rifampicin over time
- Afghanistan
- Cape Verde
How they compare
Afghanistan currently reports 70.58 against 69.01 in Cape Verde, a difference of 1.57.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Cape Verde ahead.
Afghanistan ranks 103rd and Cape Verde ranks 105th of 146 countries.
Cape Verde has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Cape Verde | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.75 | 56.97 | 28.22 | Cape Verde |
| 2020s | 57.72 | 60 | 2.28 | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Afghanistan or Cape Verde?
- Afghanistan, at 70.58 against 69.01 in Cape Verde as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Afghanistan and Cape Verde?
- 1.57, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Cape Verde?
- 5 years are reported by both, from 2017 to 2021.
- How do Afghanistan and Cape Verde rank globally for the number of people with susceptibility test result for rifampicin?
- Afghanistan ranks 103rd and Cape Verde ranks 105th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.